VentafriddaV, RipamontiC, DeConnoF, TamburiniM, CassilethBR. Symptom prevalence and control during cancer patients’ last days of life. J Palliat Care1990; 6 (3):7–11.
2.
BrueraE, MacmillanK, PitherJ, . Effects of morphine on the dyspnea of terminal cancer patients. J Pain Sympt Manag1990; 5: 341–344.
3.
BrueraE, SchoellerT, MacEachernT.Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of N of 1 randomized controlled trial. J Pain Sympt Manag1992; 7: 365–368.
4.
VentafriddaV, SpoldiE, De ConnoF.Control of dyspnea in advanced cancer patients (Letter to Editor). Chest1990; 98:1544–1545.
5.
CoyleN, AdelhardtJ, FoleyKM, . Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Sympt Manag1990; 5: 83–93.
6.
Addington-HallJM, MacDonaldLD, AndersonHR, . Dying from cancer: the views of bereaved family and friends about the experiences of terminally ill patients. Palliat Med1991; 5: 207–214.
7.
MassieMJ, HollandJ, GlassE.Delirium in terminally ill cancer patients. Am J Psychiatry1983; 140: 1048–1050.
8.
BrueraE, ChadwickS, WeinlickA, . Delirium and severe sedation in patients with terminal cancer. Cancer Treat Rep1987; 71: 787–788.
BrueraE, MillerL, McCallionJ, . Cognitive failure in patients with terminal cancer: a prospective study. J Pain Sympt Manag1992; 7: 192–195.
11.
VentafriddaV, RipamontiC, TamburiniM, . Unendurable symptoms as prognostic indicators of impending death in terminal cancer patients. Eur J Cancer1990; 26:1000–1001.
12.
HigginsonI, McCarthyM.Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?J Roy Soc Med1989; 82: 264–267.
13.
ReubenDB, MorV.Dyspnea in terminally ill patients. Chest1986; 89: 234–236.
14.
ReubenDB, MorV, HirisJ.Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med1988; 148:1586–1591.
15.
EvansC, McCarthyM.Prognostic uncertainty in terminal care: can the Karnofsky index help?Lancet1985;1:1204–1206.
16.
MorV, LalibertéL, MorrisJN, . The Karnofsky Performance Status Scale: an examination of its reliability and validity in a research setting. Cancer1984; 53:2002–2007.
17.
YatesJW, ChalmerB, McKegneyP.Evaluation of patients with advanced cancer using the Karnofsky Performance Status. Cancer1980; 45: 2220–2224.
18.
CassilethBR, LuskEJ, MillerDS, . Psychosocial correlates of survival in advanced malignant disease?N Engl J Med1985; 312:1551–1555.
19.
SjöbergM, AppelgrenL, EinarssonS, . Long-term intrathecal morphine and bupivacaine in “refractory” cancer pain. I. Results from the first series of 52 patients. Acta Anaesthesiol Scand1991;35:30–43.
20.
BrueraE, MillerMJ, KuehnRN, . Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Sympt Manag1992; 7: 82–86.
21.
VentafriddaV, De ConnoF, SaitaL, . Leucocytelymphocyte ratio as prognostic indicator of survival in cachectic cancer patients (Letter to Editor). Ann Oncol1991; 2:196.
22.
StiefelF, BrueraE.On symptom control when death is near. J Palliat Care1991; 7(1); 39–41.
